FDA Clears the Provant Therapy System for Use by Patients with Metallic Implants

Posted on Sat/21/DecemberSat/21/December by AZBio

Clinicians can now treat the post-operative pain from joint replacements and spinal fusionsContinue reading→

Regenesis expects sale or final private round next year, CEO says

Posted on Wed/16/OctoberWed/16/October by AZBio

Regenesis Biomedical profiled in BioPharm Insight…
Continue reading→

Three Arizona Companies to Present at AdvaMed 2013

Posted on Thu/1/AugustThu/1/August by AZBio

AdvaMed Announces Presenting Companies & a Special Scholarship Opportunity from RCT VenturesContinue reading→

Regenesis Bio Expands Leadership Team

Posted on Mon/16/JanuaryMon/16/January by AZBio

Regenesis Biomedical Expands Payor Sources to Increase Patient Access with addition of a new Reimbursement and Health Economics Vice President and Expands Leadership Team and Market Reach with a new COO.Continue reading→

2011 AZBio Awards Honorees Announced

Posted on Tue/20/SeptemberWed/23/January by AZBio

The Arizona BioIndustry is Moving Forward Faster in 2011

The Arizona BioIndustry Association has selected finalists and honorees for its annual awards gala to be held at the Sheraton Wild Horse Pass on Oct. 13. Awards to be presented include: 2011 Michael A. Cusanovich Educator of the Year, Fast Lane Company Awards, the Arizona Bioscience Company of the Year, the Jon W. McGarity Bioscience Leader of the Year Award, and the Arizona Bioscience Researcher of the Year Award.

Continue reading→

Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech

Posted on Wed/14/SeptemberWed/23/January by AZBio

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference: Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies.

Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the Wound Management category. The aim of the conference is to connect companies that have an innovative medical technology to parties interested in investing capital, partnering, or initiating strategic alliances.Continue reading→